Mirae Asset Global ETFs Holdings’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$383K Buy
19,217
+1,563
+9% +$36.8K ﹤0.01% 2021
2025
Q4
$468K Buy
17,654
+9,872
+127% +$254K ﹤0.01% 1926
2025
Q3
$185K Buy
+7,782
New +$139K ﹤0.01% 2358

Other funds holding KMTS

Mirae Asset Global ETFs Holdings's KMTS Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Kestra Medical Technologies (KMTS) stake by 8.9% in Q1 2026, buying an estimated $36.8K and bringing the position to 19,217 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #2021.

Mirae Asset Global ETFs Holdings first reported a position in KMTS in Q3 2025 and has held it in 3 quarters since. The position peaked at $468K in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 19,217 shares of Kestra Medical Technologies worth $383K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 1,563 Kestra Medical Technologies shares in Q1 2026, an estimated $36.8K.
  • Kestra Medical Technologies made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2021 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Kestra Medical Technologies in Q3 2025 and has held it in 3 quarters since.
  • Mirae Asset Global ETFs Holdings's Kestra Medical Technologies position peaked at $468K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.